Organization: Health Canada
Year: 2022
Month: September
Request Number: A-2022-000371
Request Summary: The Health Canada approval letter for Vertex Pharmaceutical's trial to be carried out in Canada: A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes (ClinicalTrials.gov Identifier: NCT04786262).
Disposition: Disclosed in part
Number of pages: 4